Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 21Rectal Neoplasms 10Colonic Neoplasms 6Pancreatic Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 3Adenocarcinoma Of Esophagus 3Peritoneal Neoplasms 2Neoplasms 2Liver Neoplasms 2Esophageal Neoplasms 2Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Neuropathy, Painful 1Neuralgia 1Neoplasm Recurrence, Local 1Malignant Solid Tumour 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Disease Progression 1Cold Hypersensitivity 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Carcinoma, Basal Cell 1Breast Neoplasms 1Bile Duct Neoplasms 1Advanced Rectal Cancer 1Advanced Primary Liver Cancer 1Adenocarcinoma of the Lower Rectum 1

Interventions

camrelizumab 1apatinib 1Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Advanced Primary Liver Cancer × Folfox protocol × Clear all
NCT03092895 2026-01-29

A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
157 enrolled 17 charts
Gastrointestinal

Advanced Primary Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡